DNA Fingerprinting and Phenotyping of Mycobacterium Tuberculosis Isolates from Human Immunodeficiency Virus (HIV)-seropositive and HIV-seronegative Patients in Tanzania

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1995 May 1

PMID 7615706

Citations 25

Authors

Z H Yang

I Mtoni

M Chonde

M Mwasekaga

K Fuursted

D S Askgard

J Bennedsen

P E de Haas

D van Soolingen

J D van Embden

Affiliations

Soon will be listed here.

Abstract

With the purpose of determining whether the risk of infection with a particular clone of Mycobacterium tuberculosis is influenced by the human immunodeficiency virus (HIV) status of the host, we analyzed and compared 68 mycobacterial isolates obtained from HIV-seropositive patients with tuberculosis (TB) in Dar es Salaam, Tanzania, with 66 mycobacterial isolates obtained from HIV-seronegative patients with TB in the same geographical region by using both DNA fingerprinting and classical phenotyping methods. One hundred one different IS6110 fingerprinting patterns were observed in the 134 isolates. The level of diversity of the DNA fingerprints observed in the HIV-seropositive group was comparable to the level of the diversity observed in the HIV-seronegative group. Resistance to a single anti-TB drug was found in 8.8% of the tested isolates, and 3.2% of the isolates were resistant to more than one anti-TB drug. The drug susceptibility profiles were not significantly difference between the two groups of isolates compared in the present study. Phenotypic characteristics which classify M. tuberculosis strains as belonging to the Asian subgroup correlated with a low IS6110 copy number per isolate. However, the occurrence of Asian subgroup strains was not associated with the HIV status of the patients. The results of the study suggested an equal risk of infection with a defined M. tuberculosis clone for HIV-seropositive and HIV-seronegative individuals.

Citing Articles

A comparative analysis of molecular genotypes of isolates from HIV-positive and HIV-negative patients.

Singh J, Singh N, Suresh G, Srivastava R, Aggarwal U, Behera D Front Cell Infect Microbiol. 2022; 12:953443.

PMID: 36310875 PMC: 9597297. DOI: 10.3389/fcimb.2022.953443.

Molecular Strain Typing of Mycobacterium tuberculosis: a Review of Frequently Used Methods.

Ei P, Aung W, Lee J, Choi G, Chang C J Korean Med Sci. 2016; 31(11):1673-1683.

PMID: 27709842 PMC: 5056196. DOI: 10.3346/jkms.2016.31.11.1673.

Multi drug and other forms of drug resistant tuberculosis are uncommon among treatment naïve tuberculosis patients in Tanzania.

Nagu T, Aboud S, Mwiru R, Matee M, Fawzi W, Mugusi F PLoS One. 2015; 10(4):e0118601.

PMID: 25849784 PMC: 4388561. DOI: 10.1371/journal.pone.0118601.

Genetic diversity of Mycobacterium tuberculosis isolated from tuberculosis patients in the Serengeti ecosystem in Tanzania.

Mbugi E, Katale B, Siame K, Keyyu J, Kendall S, Dockrell H Tuberculosis (Edinb). 2014; 95(2):170-8.

PMID: 25522841 PMC: 4364622. DOI: 10.1016/j.tube.2014.11.006.

Molecular epidemiology of HIV-associated tuberculosis in Dar es Salaam, Tanzania: strain predominance, clustering, and polyclonal disease.

Adams L, Kreiswirth B, Arbeit R, Soini H, Mtei L, Matee M J Clin Microbiol. 2012; 50(8):2645-50.

PMID: 22649022 PMC: 3421504. DOI: 10.1128/JCM.00624-12.

References

Collins C, Yates M, Grange J . Subdivision of Mycobacterium tuberculosis into five variants for epidemiological purposes: methods and nomenclature. J Hyg (Lond). 1982; 89(2):235-42. PMC: 2134208. DOI: 10.1017/s0022172400070765. View

Fischl M, Uttamchandani R, Daikos G, Poblete R, Moreno J, Reyes R . An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992; 117(3):177-83. DOI: 10.7326/0003-4819-117-3-177. View

Pape J, Liautaud B, Thomas F, Mathurin J, St Amand M, Boncy M . Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti. N Engl J Med. 1983; 309(16):945-50. DOI: 10.1056/NEJM198310203091603. View

van de Perre P, Rouvroy D, Lepage P, Bogaerts J, Kestelyn P, Kayihigi J . Acquired immunodeficiency syndrome in Rwanda. Lancet. 1984; 2(8394):62-5. DOI: 10.1016/s0140-6736(84)90240-x. View

DOOLEY S, Hutton M, Otten J, Breeden A, Crawford J, Pitchenik A . Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA. 1992; 268(10):1280-6. DOI: 10.1001/jama.1992.03490100078031. View

De Cock K, Soro B, Coulibaly I, Lucas S . Tuberculosis and HIV infection in sub-Saharan Africa. JAMA. 1992; 268(12):1581-7. DOI: 10.1001/jama.268.12.1581. View

Hopewell P . Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis. 1992; 15(3):540-7. DOI: 10.1093/clind/15.3.540. View

Godfrey-Faussett P, Mortimer P, Jenkins P, Stoker N . Evidence of transmission of tuberculosis by DNA fingerprinting. BMJ. 1992; 305(6847):221-3. PMC: 1882652. DOI: 10.1136/bmj.305.6847.221. View

Godfrey-Faussett P, Stoker N . Aspects of tuberculosis in Africa. 3. Genetic 'fingerprinting' for clues to the pathogenesis of tuberculosis. Trans R Soc Trop Med Hyg. 1992; 86(5):472-5. DOI: 10.1016/0035-9203(92)90072-k. View

10.

van Embden J, Cave M, Crawford J, Dale J, Eisenach K, Gicquel B . Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993; 31(2):406-9. PMC: 262774. DOI: 10.1128/jcm.31.2.406-409.1993. View

11.

Small P, Shafer R, Hopewell P, Singh S, Murphy M, Desmond E . Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med. 1993; 328(16):1137-44. DOI: 10.1056/NEJM199304223281601. View

12.

Thierry D, Pitsouni E, Costopoulos C, Guesdon J . Use of the insertion element IS6110 for DNA fingerprinting of Mycobacterium tuberculosis isolates presenting various profiles of drug susceptibility. FEMS Immunol Med Microbiol. 1993; 6(4):287-97. DOI: 10.1111/j.1574-695X.1993.tb00341.x. View

13.

Raviglione M, Sudre P, Rieder H, Spinaci S, Kochi A . Secular trends of tuberculosis in western Europe. Bull World Health Organ. 1993; 71(3-4):297-306. PMC: 2393496. View

14.

Abderrahman A, Haltiti R, Koubaji H, Gicquel B, Dellagi K . Large-scale DNA fingerprinting of Mycobacterium tuberculosis strains as a tool for epidemiological studies of tuberculosis. J Clin Microbiol. 1993; 31(9):2446-50. PMC: 265776. DOI: 10.1128/jcm.31.9.2446-2450.1993. View

15.

Small P, Hopewell P, Singh S, Paz A, Parsonnet J, Ruston D . The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med. 1994; 330(24):1703-9. DOI: 10.1056/NEJM199406163302402. View

16.

Alland D, Kalkut G, Moss A, McAdam R, Hahn J, Bosworth W . Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994; 330(24):1710-6. DOI: 10.1056/NEJM199406163302403. View

17.

Yang Z, de Haas P, van Soolingen D, van Embden J, Andersen A . Restriction fragment length polymorphism Mycobacterium tuberculosis strains isolated from Greenland during 1992: evidence of tuberculosis transmission between Greenland and Denmark. J Clin Microbiol. 1994; 32(12):3018-25. PMC: 264218. DOI: 10.1128/jcm.32.12.3018-3025.1994. View

18.

Piot P, Quinn T, TAELMAN H, Feinsod F, Minlangu K, Wobin O . Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet. 1984; 2(8394):65-9. DOI: 10.1016/s0140-6736(84)90241-1. View

19.

Selwyn P, Hartel D, Lewis V, Schoenbaum E, Vermund S, Klein R . A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989; 320(9):545-50. DOI: 10.1056/NEJM198903023200901. View

20.

Harries A . Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet. 1990; 335(8686):387-90. DOI: 10.1016/0140-6736(90)90216-r. View